Sonoma Pharmaceuticals, Inc.

8-K Other events Jun 18, 2026 10-K Fiscal year ended 2026-03-31 Jun 16, 2026 8-K Entered a material agreement; Other events Apr 30, 2026 8-K Entered a material agreement Apr 9, 2026 10-Q Quarter ended 2025-12-31 Feb 10, 2026 8-K Director or officer change Jan 28, 2026 8-K Other events Jan 12, 2026 8-K Director or officer change Jan 2, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Director or officer change Oct 23, 2025 8-K Director or officer change Oct 9, 2025 8-K Other events Sep 29, 2025 8-K Entered a material agreement Sep 26, 2025 8-K Shareholder vote results Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 10-K Fiscal year ended 2025-03-31 Jun 17, 2025 8-K Other events Apr 28, 2025 8-K Other events Apr 7, 2025 8-K Entered a material agreement Mar 25, 2025 10-Q Quarter ended 2024-12-31 Feb 5, 2025 8-K Entered a material agreement Jan 30, 2025 8-K Director or officer change Jan 3, 2025 8-K Terminated a material agreement Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Entered a material agreement; Other events Oct 22, 2024 8-K Other events Sep 20, 2024 8-K Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure Aug 28, 2024 8-K Other events Aug 23, 2024 8-K Entered a material agreement Aug 21, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Other events Jun 27, 2024 10-K Fiscal year ended 2024-03-31 Jun 17, 2024 8-K Regulation FD disclosure Apr 9, 2024 8-K Regulation FD disclosure Apr 2, 2024 8-K Delisting notice or listing-rule failure Mar 22, 2024 8-K Entered a material agreement Mar 8, 2024 10-Q Quarter ended 2023-12-31 Feb 8, 2024 8-K Regulation FD disclosure Jan 10, 2024 8-K Entered a material agreement Jan 9, 2024 8-K Director or officer change Dec 29, 2023